Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Sep 2024: Trial registered, NCT06612944
  2. 12 Nov 2024: Trial started, NCT06612944

The trials

NCT06612944: Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification

State
Under way
Phase
Phase 2
People
40 planned
Started
12 Nov 2024
Primary completion
12 Nov 2027
Arms
Intervention Group
Results
None posted
  1. 25 Sep 2024: Trial registered
  2. 12 Nov 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.